These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 26933749)
21. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
22. [New therapeutic strategies in chronic inflammatory bowel disease]. Kucharzik T; Maaser C Dtsch Med Wochenschr; 2015 Feb; 140(3):194-7. PubMed ID: 25658408 [No Abstract] [Full Text] [Related]
25. [Conservative treatment of ulcerative colitis and Crohn's disease in childhood]. Bläker F Monatsschr Kinderheilkd; 1981 Feb; 129(2):117-8. PubMed ID: 6112669 [No Abstract] [Full Text] [Related]
26. Clinical Outcomes Following a Switch from Remicade® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort Study. Smits LJ; Derikx LA; de Jong DJ; Boshuizen RS; van Esch AA; Drenth JP; Hoentjen F J Crohns Colitis; 2016 Nov; 10(11):1287-1293. PubMed ID: 27095751 [TBL] [Abstract][Full Text] [Related]
28. Corticosteroids for the management of ulcerative colitis and Crohn's disease. Jewell DP Gastroenterol Clin North Am; 1989 Mar; 18(1):21-34. PubMed ID: 2646220 [TBL] [Abstract][Full Text] [Related]
29. [Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease]. Hinojosa J; Molés JR; Nos P; Hoyos M; Ramírez JJ; Primo J; Fernández J; Berenguer J Rev Esp Enferm Dig; 1995 Nov; 87(11):775-80. PubMed ID: 8534531 [TBL] [Abstract][Full Text] [Related]
30. Investigation of IL23R, JAK2, and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population. Can G; Tezel A; Gürkan H; Tozkır H; Ünsal G; Soylu AR; Ümit HC Turk J Gastroenterol; 2016 Nov; 27(6):525-536. PubMed ID: 27852544 [TBL] [Abstract][Full Text] [Related]
31. Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD). Franchimont D; Ferrante M; Louis E; De Vos M; Dewit O; Van Hootegem P; Moreels T; Liefferinckx C; Bossuyt P; Baert F; Rahier JF; Vermeire S Acta Gastroenterol Belg; 2018; 81(1):49-53. PubMed ID: 29562378 [No Abstract] [Full Text] [Related]
32. Medical treatment of ulcerative colitis and Crohn's disease. Rhodes JM J Clin Hosp Pharm; 1983 Sep; 8(3):219-32. PubMed ID: 6138368 [No Abstract] [Full Text] [Related]
33. Biosimilars for Management of Crohn Disease. Nielsen OH; Ainsworth MA Ann Intern Med; 2019 Jan; 170(2):129-130. PubMed ID: 30535358 [No Abstract] [Full Text] [Related]
34. [Does rational therapy exist in patients with Crohn's disease and ulcerative colitis?]. Lukás M Vnitr Lek; 2011 Dec; 57(12):1029-33. PubMed ID: 22277037 [TBL] [Abstract][Full Text] [Related]
35. A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis. Tung J; Loftus EV; Freese DK; El-Youssef M; Zinsmeister AR; Melton LJ; Harmsen WS; Sandborn WJ; Faubion WA Inflamm Bowel Dis; 2006 Dec; 12(12):1093-100. PubMed ID: 17119382 [TBL] [Abstract][Full Text] [Related]
36. Acute severe pulmonary toxicity due to biosimilar infliximab in a Crohn's disease patient. Ríos León R; Jaureguizar Oriol A; López-Sanromán A; Jiménez Castro D; Nieto Royo R; Albillos Martínez A Gastroenterol Hepatol; 2019 Feb; 42(2):104-105. PubMed ID: 29519679 [No Abstract] [Full Text] [Related]
37. [Immunodepressants in the treatment of Crohn's disease and non-specific ulcerative colitis]. Radbil' OS Klin Med (Mosk); 1976 Mar; 54(3):8-14. PubMed ID: 787661 [No Abstract] [Full Text] [Related]